Hong-Yan Lin, Hong-Wei Han, Yin-Song Wang, De-Liu He, Wen-Xue Sun, Lu Feng, . . . Yong-Hua Yang. (2020). Shikonin and 4-hydroxytamoxifen synergistically inhibit the proliferation of breast cancer cells through activating apoptosis signaling pathway in vitro and in vivo. BMC.
Chicago Style (17th ed.) CitationHong-Yan Lin, et al. Shikonin and 4-hydroxytamoxifen Synergistically Inhibit the Proliferation of Breast Cancer Cells Through Activating Apoptosis Signaling Pathway in Vitro and in Vivo. BMC, 2020.
MLA (9th ed.) CitationHong-Yan Lin, et al. Shikonin and 4-hydroxytamoxifen Synergistically Inhibit the Proliferation of Breast Cancer Cells Through Activating Apoptosis Signaling Pathway in Vitro and in Vivo. BMC, 2020.
Warning: These citations may not always be 100% accurate.